Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysis

J Am Coll Cardiol. 2005 Aug 16;46(4):599-605. doi: 10.1016/j.jacc.2005.05.034.

Abstract

Objectives: We report intravascular ultrasound (IVUS) findings after crush-stenting of bifurcation lesions.

Background: Preliminary results with the crush-stent technique are encouraging; however, isolated reports suggest that restenosis at the side branch (SB) ostium continues to be a problem.

Methods: Forty patients with bifurcation lesions underwent crush-stenting with the sirolimus-eluting stent. Postintervention IVUS was performed in both branches in 25 lesions and only the main vessel (MV) in 15 lesions; IVUS analysis included five distinct locations: MV proximal stent, crush area, distal stent, SB ostium, and SB distal stent.

Results: Overall, the MV minimum stent area was larger than the SB (6.7 +/- 1.7 mm2 vs. 4.4 +/- 1.4 mm2, p < 0.0001, respectively). When only the MV was considered, the minimum stent area was found in the crush area (rather than the proximal or MV distal stent) in 56%. When both the MV and the SB were considered, the minimum stent area was found at the SB ostium in 68%. The MV minimum stent area measured <4 mm2 in 8% of lesions and <5 mm2 in 20%. For the SB, a minimum stent area <4 mm2 was found in 44%, and a minimum stent area <5 mm2 in 76%, typically at the ostium. "Incomplete crushing"--incomplete apposition of SB or MV stent struts against the MV wall proximal to the carina--was seen in >60% of non-left main lesions.

Conclusions: In the majority of bifurcation lesions treated with the crush technique, the smallest minimum stent area appeared at the SB ostium. This may contribute to a higher restenosis rate at this location.

MeSH terms

  • Angioplasty, Balloon, Coronary / instrumentation
  • Angioplasty, Balloon, Coronary / methods*
  • Blood Vessel Prosthesis Implantation / methods*
  • Coronary Artery Disease / diagnostic imaging
  • Coronary Artery Disease / therapy*
  • Coronary Stenosis / diagnostic imaging
  • Coronary Stenosis / therapy*
  • Drug Delivery Systems
  • Female
  • Humans
  • Male
  • Middle Aged
  • Risk Factors
  • Sirolimus / administration & dosage
  • Sirolimus / therapeutic use
  • Stents*
  • Ultrasonography, Interventional*

Substances

  • Sirolimus